Antisauvagine-30 TFA aSvg-30 TFA,98.01%

产品编号:Bellancom-P1107A| 分子式:C163H275N48F3O49S| 分子量:3764.28

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-P1107A
3200.00 杭州 北京(现货)
Bellancom-P1107A
5500.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Antisauvagine-30 TFA aSvg-30 TFA

产品介绍 Antisauvagine-30 TFA (aSvg-30 TFA) 是有效的、高度选择性的、竞争性的 CRF2 受体 的多肽拮抗剂。Antisauvagine-30 TFA对 mCRFR2β 和 CRFR1 的 Kd 值分别为1.4 nM 和150 nM。
生物活性

Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist. Antisauvagine-30 TFA exhibits a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively[4].

体外研究

Antisauvagine-30 (aSvg-30) prevents stress-enhanced fear conditioning and Mek-1/2-dependent activation of Erk-1/2 and p90Rsk-1. Antisauvagine-30 (aSvg-30) did not affect the phosphorylation of the PKA regulatory subunit II of stressed mice.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Antisauvagine-30 (aSvg-30; i.h. 400 ng/0.5 μl per mouse) selectively prevents the stress-induced enhancement of fear conditioning without affecting the fear conditioning of nonstressed mice.
Antisauvagine-30 (aSvg-30) injected i.c.v. elicits a significant anxiogenic effect.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nine-week-old male BALB/c mice.
Dosage: 400 ng/0.5 μl per mouse.
Administration: Administered bilaterally by a microinjector (intrahippocampal (i.h.) injection).
Result: Prevented the stress-induced enhancement of fear conditioning.
体内研究

Antisauvagine-30 (aSvg-30; i.h. 400 ng/0.5 μl per mouse) selectively prevents the stress-induced enhancement of fear conditioning without affecting the fear conditioning of nonstressed mice.
Antisauvagine-30 (aSvg-30) injected i.c.v. elicits a significant anxiogenic effect.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nine-week-old male BALB/c mice.
Dosage: 400 ng/0.5 μl per mouse.
Administration: Administered bilaterally by a microinjector (intrahippocampal (i.h.) injection).
Result: Prevented the stress-induced enhancement of fear conditioning.
性状Solid
溶解性数据
In Vitro: 

H2O : 25 mg/mL (6.64 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 0.2657 mL 1.3283 mL 2.6566 mL
5 mM 0.0531 mL 0.2657 mL 0.5313 mL
10 mM --- --- ---
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Sealed storage, away from moisture

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服